The DOI matches its Crossref record.
Release of Incompletely Processed Proinsulin Is the Cause of the Disproportionate Proinsulinemia of NIDDM
Open accessAbstract
The production of insulin from proinsulin involves cleavage of intact proinsulin into proinsulin conversion intermediates by the processing of enzymes PC2 and PC3 before fully processed insulin is produced. Intact proinsulin and these conversion intermediates are measured in many immunoreactive insulin (IRI) assays, and therefore contribute to the absolute IRI measurement. The proportion of basal IRI made up of proinsulin (PI)-like molecules (PI/IRI) is increased in NIDDM. Whether stimulated IRI levels are similarly made up of disproportionately increased PI/IRI or whether the relative proportions of proinsulin and its conversion intermediates are altered has not been evaluated. An index of the efficiency of proinsulin processing within the pancreatic β-cell can be achieved by measuring PI/IRI immediately following acute stimulation of β-cell secretion, and then determining the proportion of intact proinsulin and proinsulin conversion intermediates contributing to circulating proinsulin-like molecules. In this study, we determined the PI/IRI levels under basal and arginine-stimulated conditions in 17 healthy and 16 NIDDM subjects; high-performance liquid chromatography (HPLC) was also performed in a subset of these subjects to measure the relative contribution of intact proinsulin and its conversion intermediates to total proinsulin-like molecules. In NIDDM subjects, levels of both basal (44.6 ± 9.6 vs. 9.3 ± 1.5 pmol/1; P = 0.0007) and stimulated (64.0 ± 12.7 vs. 19.8 ± 2.8 pmol/1; P = 0.001) proinsulin-like molecules were higher than in healthy subjects. Although IRI was higher in NIDDM than in control subjects under basal conditions (106 ± 19 vs. 65.1 ± 8.1 pmol/1; P = 0.05), it was lower in NIDDM than in control subjects following stimulation (increment: 257 ± 46 vs. 416 ±51 pmol/1; P = 0.03). PWRI ratios were increased in NTODM subjects under both basal (43.3 ± 5.0 vs. 14.0 ± 1.3%; P < 0.0001) and stimulated (increment: 10.1 ± 2.1 vs. 2.5 ± 0.2%; P = 0.0006) conditions, compatible with the release of a disproportionately increased amount of proinsulin-like products. HPLC analysis revealed that, in the stimulated state, intact proinsulin made up 40.1 ± 6.7% of proinsulin-like molecules in NIDDM individuals (n = 9) and 30.1 ± 5.6% in healthy subjects (n = 7; NS). The remainder of the proinsulin-like molecules comprised the des-31,32-split proinsulin conversion intermediate. The increase in PI/IRI in NIDDM under basal and especially under stimulated conditions suggests that proinsulin conversion is indeed perturbed in this disorder. Because the relative proportions of intact and des-31,32-split proinsulin are similar in both healthy and NIDDM subjects, the orderly cleavage of proinsulin at its two junctions appears preserved. However, at the time of exocytosis, the secretory granule in the islet of NIDDM subjects contains an increased proportion of incompletely processed proinsulin, presumably reflecting a slower rate of conversion or granules' reduced time of residence in β-cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“inefficient proinsulin processing to insulin [77, 78, 79, 80, 81, 82, 83] and a reduction in the release of islet amyloid polypeptide (IAPP), known also as amylin [84, 85, 86, 87], have been observed in established Type 2 diabetes.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [83]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 101–200 of 220
Lx, G., Liu, H., & Yin, F. (2014) · PubMed · Cited by 24
Khemtémourian, L., Casarramona, G. L., Suylen, D. P. L., Hackeng, T. M., Meeldijk, J. D., KRUIJFF, B. D., Höppener, J. W. M., & Killian, J. A. (2009) · Biochemistry · doi:10.1021/bi901076d · Cited by 24
Zhang, F., Dey, D., Bränström, R., Forsberg, L. E., Lu, M. H., Zhang, Q., & Sjöholm, Å. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00444.2008 · Cited by 23
The Amyloid Forming Peptides Islet Amyloid Polypeptide and Amyloid β Interact at the Molecular Level
Wang, Y., & Westermark, G. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011153 · Cited by 23
Pfützner, A., Kunt, T., Langenfeld, M. R. W., Löbig, M., Knesovic, M., & Forst, T. M. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.189 · Cited by 23
Stümvoll, M., Fritsche, A., Stefan, N., Hardt, E., & Häring, H. U. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7331 · Cited by 22
Protein phosphatases in pancreatic islets
Ortsäter, H., Grankvist, N., Honkanen, R. E., & Sjöholm, Å. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0002 · Cited by 21
Hyperproinsulinaemia and risk of Type 2 diabetes mellitus in women
Schulze, M. B., Solomon, C. G., Rifai, N., Cohen, R. M., Sparrow, J., Hu, F. B., & Manson, J. E. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01585.x · Cited by 22
Growth hormone signaling in pancreatic β-cells—Calcium handling regulated by growth hormone
Zhang, F., Sjöholm, Å., & ZHANG, Q. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.06.001 · Cited by 21
Rohli, K. E., Boyer, C. K., Bearrows, S. C., Moyer, M. R., Elison, W. S., Bauchle, C. J., Blom, S. E., Yu, C.-L., Pope, M. R., 张建朝, et al. (2022) · Function · doi:10.1093/function/zqac051 · Cited by 24
Kaas, A., Andersen, M. L. M., Fredheim, S., Hougaard, P., Buschard, K., Petersen, J. S., de Beaufort, C. E., Robertson, K. J., Hansen, L., Mortensen, H. B., et al. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00812.x · Cited by 21
Impaired Proinsulin Processing is a Characteristic of Transplanted Islets
Klimek-Abercrombie, A. M., Soukhatcheva, G., Thompson, D. M., Warnock, G. L., Salehi, M., Rilo, H., DAlessio, D., Meneilly, G. S., Panagiotopoulos, C., & Verchere, C. B. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02740.x · Cited by 21
Inoguchi, T., Umeda, F., KAKIMOTO, M., Sako, Y., Ishii, H., NODA, K., Kunisaki, M., Imamura, M., YU, H.-Y., Etoh, T., et al. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.763 · Cited by 21
The serum levels of proinsulin and their relationship with IGFBP‐1 in obese children
Kamoda, T., Saitoh, H., Inudoh, M., Miyazaki, K., & Matsui, A. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00479.x · Cited by 20
Stefan, N., Stümvoll, M., Häring, H., & Fritsche, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1519-a · Cited by 20
Boyer, C. K., Bauchle, C. J., Zhang, J., Wang, Y., & Stephens, S. B. (2023) · Scientific Reports · doi:10.1038/s41598-023-32322-z · Cited by 19
Halban, P. A., & Irminger, J.-C. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-05-0299 · Cited by 16
Self-citationBiogenesis of the Insulin Secretory Granule in Health and Disease
Guest, P. C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12668-1_2 · Cited by 15
Ionescu-Tirgoviste, C., & Guja, C. (2007) · Cited by 15
McDonald, C. G., Ryan, E. A., Paty, B. W., Senior, P. A., Marshall, S. M., Lakey, J. R. T., & Shapiro, A. M. J. (2004) · Transplantation · doi:10.1097/01.tp.0000134973.77057.39 · Cited by 15
Bates, H. E., Sirek, A., Kiràly, M. A., Yue, J. T. Y., Riddell, M. C., Matthews, S. G., & Vranić, M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90378.2008 · Cited by 15
Couch, C. A., Piccinini, F., Fowler, L. A., Garvey, W. T., & Gower, B. A. (2023) · Diabetes Care · doi:10.2337/dc22-1763 · Cited by 14
Kley, S., Caffall, Z. F., Tittle, E. E., Ferguson, D. C., & Hoenig, M. E. (2007) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2007.09.001 · Cited by 13
Amyloid and Transplanted Islets
Rickels, M. R., Collins, H. W., & Naji, A. (2008) · New England Journal of Medicine · doi:10.1056/nejmc082011 · Cited by 13
Atmodjo, W. L., Larasati, Y. O., Jo, J., Nufika, R., NAOMI, S., & Winoto, I. L. (2021) · In Vivo · doi:10.21873/invivo.12258 · Cited by 12
Thomsen, M. N., Skytte, M. J., Samkani, A., Astrup, A. V., Fenger, M., Frystyk, J., Hartmann, B., Holst, J. J., Larsen, T. M., Madsbad, S., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.933118 · Cited by 12
Yang, Y., Wang, M., Tong, J., Dong, Z., Deng, M., Ren, X., Li, H., Yang, J., Meng, Z., Sun, J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00549 · Cited by 12
Arcelloni, C., Falqui, L., Martinenghi, S., Pontiroli, A. E., & Paroni, R. C. (1998) · Electrophoresis · doi:10.1002/elps.1150190843 · Cited by 12
Proinsulin: recent observations and controversies
Mackin, R. B. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050196 · Cited by 12
Arcelloni, C., Falqui, L., Martinenghi, S., Stabilini, A., Pontiroli, A. E., & Paroni, R. C. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660437 · Cited by 12
Ozawa, S., Katsuta, H., Suzuki, K., Takahashi, K., Tanaka, T., Sumitani, Y., Nishida, S., Yoshimoto, K., & Ishida, H. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej13-0506 · Cited by 11
Early clinical studies with liraglutide
Schmidt, W. E. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02500.x · Cited by 11
Bolinder, J., Fernlund, P., Borg, H., Arnqvist, H., Björk, E., Blohmé, G., Eriksson, J. W., Nyström, L., Ostman, J., & Sundkvist, G. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510500261869 · Cited by 10
Proinsulin in Girls: Relationship to Obesity, Hyperinsulinemia, and Puberty
Chin, D., Oberfield, S. E., Silfen, M. E., McMahon, D. J., Manibo, A. M., Accili, D., & Levine, L. S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011535 · Cited by 11
Cook, T. W., Wilstermann, A. M., Mitchell, J. T., Arnold, N. E., Rajasekaran, S., Bupp, C. P., & Prokop, J. W. (2023) · Biomolecules · doi:10.3390/biom13020257 · Cited by 12
Beta-cell function is disrupted in patients with systemic lupus erythematosus
Dorta, A. G., Quevedo-Abeledo, J. C., Rúa‐Figueroa, Í., de Vera-González, A. M., Delgado, A. G., Medina-Vega, L., González-Rivero, A. F., Francisco-Hernández, F., González-Gay, M. Á., & Ferraz‐Amaro, I. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa874 · Cited by 12
Røder, M. E., & Kahn, S. E. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s22 · Cited by 10
Self-citationParallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance
MacNamara, C. M., Barrow, B. A., Manley, S. E., Lévy, J., Clark, A., & Turner, R. C. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00188-1 · Cited by 10
Impact of uncoupling protein-2 overexpression on proinsulin processing
Kashemsant, N., & Chan, C. B. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02091 · Cited by 9
Different β‐cell secretory phenotype in non‐obese compared to obese early type 2 diabetes
Gudipaty, L., Rosenfeld, N. K., Fuller, C. S., Cuchel, M., & Rickels, M. R. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3295 · Cited by 9
Ekholm, E., Shaat, N., & Holst, J. J. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0312-y · Cited by 9
Jin, J., Yu, Y., Yu, H., Wang, C., & Zhang, X. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.04.020 · Cited by 9
Truncated (des-[27-31]) C-peptide is not a major secretory product of human islets
Paoletta, M., Kahn, S. E., & Halban, P. A. (2002) · Diabetologia · doi:10.1007/s00125-002-0938-y · Cited by 9
Self-citationAbnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
Alsahli, M., & Gerich, J. E. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch10 · Cited by 11
Kalirin/Trio Rho GDP/GTP exchange factors regulate proinsulin and insulin secretion
Dufurrena, Q., Bäck, N., Mains, R. E., Hodgson, L., Tanowitz, H. B., Mandela, P., Eipper, B. A., & Kuliawat, R. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0048 · Cited by 7
Khatib, A., & Amawi, K. F. (2020) · Medical Archives · doi:10.5455/medarh.2020.74.168-171 · Cited by 8
Hyperproinsulinemia in obesity and in type 2 diabetes and its relation to cardiovascular disease
Røder, M. E. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1331735 · Cited by 8
Zheng, H.-L., Xing, Y., Li, F., Ding, W., & Ye, S. (2020) · Medicine · doi:10.1097/md.0000000000019685 · Cited by 8
Takahashi, M., 柴崎美紗, Echizen, H., & Kushiyama, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236603 · Cited by 8
Wiedeman, A. M., Panagiotopoulos, C., & Devlin, A. M. (2020) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-0259 · Cited by 9
Kahn, S. E. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2004.02.005 · Cited by 8
Self-citationMitochondrial Gene Expression in Diabetes Mellitus: Effect of Nutrition
Berdanier, C. D. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2001.tb06990.x · Cited by 8
β‐Cell Dysfunction in Type 2 Diabetes
Utzschneider, K. M., & Kahn, S. E. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0403 · Cited by 8
Self-citationPancreatic Islet Amyloid and Diabetes
Clark, A., & Moffitt, J. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-36534-3_10 · Cited by 7
Evans‐Molina, C. (2024) · Diabetes · doi:10.2337/dbi23-0030 · Cited by 7
Elkhafif, N. M., Borot, S., Morel, P., Demuylder-Mischler, S., Giovannoni, L., Toso, C., Bosco, D., & Berney, T. (2013) · Diabetes Care · doi:10.2337/dc12-2710 · Cited by 7
Sullivan, C. A. W., Cacicedo, J. M., Rajendran, I., & Steenkamp, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207065 · Cited by 7
Probing the Meaning of Persistent Propeptide Release in Type 1 Diabetes
Kahn, S. E., Templin, A. T., Hull, R. L., & Verchere, C. B. (2019) · Diabetes Care · doi:10.2337/dci18-0054 · Cited by 6
Self-citationRegulation of Insulin Secretion in Vivo
Vidal, J., & Kahn, S. E. (2001) · Endocrine updates · doi:10.1007/978-1-4615-1597-5_7 · Cited by 7
Self-citationKatsuta, H., Ozawa, S., Suzuki, K., Takahashi, K., Tanaka, T., Sumitani, Y., Nishida, S., Kondo, T., Hosaka, T., Inukai, K., et al. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej14-0611 · Cited by 6
Age‐related changes of proinsulin processing in diabetic and non‐diabetic Japanese individuals
Yoshino, H., Kawakami, K., Yoshino, G., & Hirose, T. (2018) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13303 · Cited by 6
Patel, K., Levesque, K., Mark, V., Pierini, E., Rojas, B., Ahlers, M. J., Shah, A. M., & Laferrère, B. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12964 · Cited by 6
Biological Effects of C‐peptide and Proinsulin
Wahren, J., Ekberg, K., Shafqat, J., Johansson, J., Johansson, B., & Jörnvall, H. (2003) · doi:10.1002/0470862092.d0207 · Cited by 6
Tobin, B. W., & Miller, G. D. (2001) · Journal of Nutrition · doi:10.1093/jn/131.2.333s · Cited by 6
Lorenzo, C., Hanley, A. J., Rewers, M., & Haffner, S. M. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0565-3 · Cited by 5
Hassan, F., El-Said, E.-S. E.-S., El‐Sayed, G., El‒Sayed, S. A. E., & Awadin, W. F. (2020) · Comparative Clinical Pathology · doi:10.1007/s00580-020-03093-0 · Cited by 5
Abedini, A., & Raleigh, D. P. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch23 · Cited by 5
Rohli, K. E., Boyer, C. K., Bearrows, S. C., Moyer, M. R., Elison, W. S., Bauchle, C. J., Blom, S. E., Yu, C.-L., Pope, M. R., Zhang, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.22.461417 · Cited by 5
Nielsen, B. U., Mathiesen, I. H. M., Møller, R., Krogh‐Madsen, R., Katzenstein, T. L., Pressler, T., Shaw, J., Ritz, C., Rickels, M. R., Stefanovski, D., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1249876 · Cited by 4
YY1-mediated regulation of type 2 diabetes via insulin
Kosasih, F. R., & Bonavida, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821909-6.00005-5 · Cited by 4
Islet amyloid deposits preferentially in the highly functional and most blood-perfused islets
Ullsten, S., Bohman, S., Oskarsson, M. E., Nilsson, K. P. R., Westermark, G. T., & Carlsson, P. (2017) · Endocrine Connections · doi:10.1530/ec-17-0148 · Cited by 4
Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV‐infected patients
Haugaard, S. B., Andersen, O., Hales, C. N., Halsall, I., Rosenfalck, A. M., Iversen, J., & Madsbad, S. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01640.x · Cited by 4
Stickle, D. F., Reynolds, M. A., Morris, M. D., & Quon, M. J. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00072-8 · Cited by 4
THE ROLE OF THE PANCREATIC AMYLOID IN THE PATHOGENESIS OF TYPE 2 DIABETES
Ionescu-Tirgoviste, C., Guja, C., Vasilica, C., & Gutu, D. (2010) · Cited by 4
Physiological and Pathophysiological Role of Islet Amyloid Polypeptide (IAPP, Amylin)
Westermark, G. T. (2011) · Springer eBooks · doi:10.1007/978-1-4419-6956-9_15 · Cited by 4
Miya, A., Nakamura, A., Nomoto, H., Kameda, H., & Atsumi, T. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej23-0525 · Cited by 3
Non-cross-linking advanced glycation end products affect prohormone processing
Brings, S., Mier, W., Beijer, B., Kliemank, E., Herzig, S., Szendroedi, J., Nawroth, P. P., & Fleming, T. (2023) · Biochemical Journal · doi:10.1042/bcj20230321 · Cited by 3
Proinsulin and age in general population.
Ateia, S., Rusu, E., Cristescu, V., Enache, G., Cheţa, D., & Radulian, G. (2013) · Europe PMC (PubMed Central) · Cited by 3
Palmer, J. P., Kahn, S. E., Schwartz, M. W., Taborsky, G. J., & Woods, S. C. (2020) · Diabetes Care · doi:10.2337/dci19-0068 · Cited by 3
Self-citationA cirurgia bariátrica no controle do Diabetes Mellitus tipo 2: uma revisão narrativa
Cardoso, L. B., Paula, A. B. C. D., Bacha, F. L., Nascimento, G. M., Silva, Í. G., Carvalho, J. R. B. D., Silva, M. B. D. C., Alvares, S. F. W., Carvalho, L. V. D. O., & Barcelos, P. S. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n1-361 · Cited by 2
Glycosaminoglycans, Proteoglycans, and Conformational Disorders
Cole, G. J., & Liu, I.-H. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_5 · Cited by 2
Genomics-Proteomics and Stroke
Gwinn, K. A., & Dawson, V. L. (2004) · Stroke · doi:10.1161/01.str.0000143328.98154.33 · Cited by 2
In Vitro Indicators of Metabolism of Natural Compounds
Shreeve, W. W. (2003) · Springer eBooks · doi:10.1007/978-3-642-55539-8_14 · Cited by 2
Kim, S. K., Kim, J. H., Park, J. Y., No, H. S., Jang, K., Heo, J. S., Choi, S. H., Choi, D. W., & Kim, K. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.04.020 · Cited by 2
Sundaram, S. P. T., Cholarajan, R. N., Sahnthirappan, S., & Ramasamy, M. (2022) · Journal of Research in Siddha Medicine · doi:10.4103/jrsm.jrsm_23_22 · Cited by 1
Yabe, S., Nishida, J., Fukuda, S., Kin, T., Nishiyama, A., Tamura, T., Takeda, F., Tamura-Nakano, M., Shirakawa, J., & Okochi, H. (2025) · Gene · doi:10.1016/j.gene.2025.149639 · Cited by 1
Degaki, T. L., Lopes, D. H. J., & Sogayar, M. C. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_7 · Cited by 1
ROLE OF STROMAL CELL-DERIVED FACTOR 1 IN PROLIFERATIVE RETINOPATHY
Butler, J. M. (2006) · Cited by 1
Evaluation of use of singleton measurements of C-peptide by RIA
Stickle, D. F., & McNeil, S. E. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00206-x · Cited by 1
Quan, H., Fang, T., Lin, L., Lü, L., Ou, Q., Zhang, H., Chen, K., & Zhou, Z. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01102-1 · Cited by 1
Shardlow, E., Brown, L., & Exley, C. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.127027 · Cited by 1
Prohormone processing and Type 2 diabetes
Jackson, R. S. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00526-5.x · Cited by 1
Andersson, A., Bohman, S., Hakan, L., Paulsson, J. F., Schultz, S. W., Westermark, G. T., & Westermark, P. (2008) · Cited by 1
Höfer, M. (2007) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.6712
Pancreatic beta-cell failure in the pathogenesis of type 2 diabetes
Gunton, J. E., & Girgis, C. M. (2012) · The Sydney eScholarship Repository (The University of Sydney)
β-Cell Dysfunction and Chronic Hyperglycaemia
Leahy, J. L. (2001) · Endocrine updates · doi:10.1007/978-1-4615-1669-9_3
Pharmacogenetics in cerebrovascular disease
GWINNHARDY, K. (2003) · Seminars in Cerebrovascular Diseases and Stroke · doi:10.1053/scds.2003.00014
Paulsson, J. F. (2006) · DiVA (Linkoping University)
Alteration in Pancreatic Islet Function in Human Immunodeficiency Virus
Haugaard, S. B. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2014.06.004
Metadata
- Authors
- Kahn, S. E., & Halban, P. A.
- Affiliations
- University of Washington (US)
- Laboratoires de Recherche Louis Jeantet, Centre Medical Universitaire Geneva, Switzerland
- ORCID
- Kahn, Steven E
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1997-11-01
- Volume
- 46
- Issue
- 11
- Pages
- 1725-1732
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2124706352
- Cited by
- 221
- References
- 0
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 3 · 2023: 6 · 2022: 7 · 2021: 14 · 2020: 12 · 2019: 8 · 2018: 6 · 2017: 4 · 2016: 1 · 2015: 3 · 2014: 11 · 2013: 6 · 2012: 5
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (2r01dk012829-36)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 12829, DK-17047, P30DK017047)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- proinsulin, type 2 diabetes, proinsulin processing, proinsulin C-peptide, arginine stimulation, beta-cell secretion, insulin production
- MeSH terms
- Adult, Arginine, Chromatography, High Pressure Liquid, Diabetes Mellitus, Type 2, Female, Humans, Insulin, Male, Middle Aged, Proinsulin, Protein Precursors, Protein Processing, Post-Translational, Radioimmunoassay, Reference Values, Regression Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review